Track the Parallax Health Sciences, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Technology sector, Parallax Health Sciences, INC. has logged 1 reports. Market capitalisation: €778.5bn. The latest transaction was filed on 17 March 2022 (J). Among the most active insiders: WITHROW EDWARD W III. Every trade is openly available.
Analysts rate Parallax Health Sciences, INC. Strong Buy (bullish), based on 41 analysts. Average price target: US$584.24.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration